Cited 0 times in
Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid.
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yang, KS | - |
dc.contributor.author | Kang, SW | - |
dc.contributor.author | Woo, HA | - |
dc.contributor.author | Hwang, SC | - |
dc.contributor.author | Chae, HZ | - |
dc.contributor.author | Kim, K | - |
dc.contributor.author | Rhee, SG | - |
dc.date.accessioned | 2011-07-20T01:20:09Z | - |
dc.date.available | 2011-07-20T01:20:09Z | - |
dc.date.issued | 2002 | - |
dc.identifier.issn | 0021-9258 | - |
dc.identifier.uri | http://repository.ajou.ac.kr/handle/201003/3469 | - |
dc.description.abstract | By following peroxiredoxin I (Prx I)-dependent NADPH oxidation spectrophotometrically, we observed that Prx I activity decreased gradually with time. The decay in activity was coincident with the conversion of Prx I to a more acidic species as assessed by two-dimensional gel electrophoresis. Mass spectral analysis and studies with Cys mutants determined that this shift in pI was due to selective oxidation of the catalytic site Cys(51)-SH to Cys(51)-SO(2)H. Thus, Cys(51)-SOH generated as an intermediate during catalysis appeared to undergo occasional further oxidation to Cys(51)-SO(2)H, which cannot be reversed by thioredoxin. The presence of H(2)O(2) alone was not sufficient to cause oxidation of Cys(51) to Cys(51)-SO(2)H. Rather, the presence of complete catalytic components (H(2)O(2), thioredoxin, thioredoxin reductase, and NADPH) was necessary, indicating that such hyperoxidation occurs only when Prx I is engaged in the catalytic cycle. Likewise, hyperoxidation of Cys(172)/Ser(172) mutant Prx I required not only H(2)O(2), but also a catalysis-supporting thiol (dithiothreitol). Kinetic analysis of Prx I inactivation in the presence of a low steady-state level (<1 microm) of H(2)O(2) indicated that Prx I was hyperoxidized at a rate of 0.072% per turnover at 30 degrees C. Hyperoxidation of Prx I was also detected in HeLa cells treated with H(2)O(2). | - |
dc.language.iso | en | - |
dc.subject.MESH | Amino Acid Sequence | - |
dc.subject.MESH | Antioxidants | - |
dc.subject.MESH | Catalysis | - |
dc.subject.MESH | Catalytic Domain | - |
dc.subject.MESH | Cysteine | - |
dc.subject.MESH | Hela Cells | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Hydrogen Peroxide | - |
dc.subject.MESH | Hydrogen-Ion Concentration | - |
dc.subject.MESH | Molecular Sequence Data | - |
dc.subject.MESH | Mutation | - |
dc.subject.MESH | NADP | - |
dc.subject.MESH | Oxidants | - |
dc.subject.MESH | Oxidation-Reduction | - |
dc.subject.MESH | Peptides | - |
dc.subject.MESH | Peroxidases | - |
dc.subject.MESH | Peroxiredoxins | - |
dc.subject.MESH | Recombinant Proteins | - |
dc.subject.MESH | Spectrometry, Mass, Electrospray Ionization | - |
dc.subject.MESH | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | - |
dc.subject.MESH | Thioredoxin-Disulfide Reductase | - |
dc.subject.MESH | Thioredoxins | - |
dc.title | Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid. | - |
dc.type | Article | - |
dc.identifier.pmid | 12161445 | - |
dc.identifier.url | http://www.jbc.org/cgi/pmidlookup?view=long&pmid=12161445 | - |
dc.contributor.affiliatedAuthor | 황, 성철 | - |
dc.type.local | Journal Papers | - |
dc.identifier.doi | 10.1074/jbc.M206626200 | - |
dc.citation.title | The Journal of biological chemistry | - |
dc.citation.volume | 277 | - |
dc.citation.number | 41 | - |
dc.citation.date | 2002 | - |
dc.citation.startPage | 38029 | - |
dc.citation.endPage | 38036 | - |
dc.identifier.bibliographicCitation | The Journal of biological chemistry, 277(41). : 38029-38036, 2002 | - |
dc.identifier.eissn | 1083-351X | - |
dc.relation.journalid | J000219258 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.